China NMPA Product Recall - Cancer Antigen 15-3 (CA15-3) Detection Kit (Chemiluminescence Method)
China NMPA product recall for Cancer Antigen 15-3 (CA15-3) Detection Kit (Chemiluminescence Method) by Fuji Xerbio Co., Ltd. published December 07, 2021. Recall level: Level 3 Recall. On December 7, 2021, Rebio (Shanghai) Diagnostic Technology Co., Ltd., in collaboration with Fuji Re
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Cancer Antigen 15-3 (CA15-3) Detection Kit (Chemiluminescence Method) by Fuji Xerbio Co., Ltd. published December 07, 2021. Recall level: Level 3 Recall. On December 7, 2021, Rebio (Shanghai) Diagnostic Technology Co., Ltd., in collaboration with Fuji Re
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Fuji Xerbio Co., Ltd.Inspection Date
Unknown Date
Product Type
ID: 36111cee-3941-4819-b0c1-75c541d4bf11
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox